Plasma DPP-4 activity ( A , C , E , and G ), plasma TG and AUC over 180 minutes ( B , D , F , and H , left and middle), and plasma levels of active GLP-1 before and 10 minutes after olive oil gavage ( B , D , F ,and H , right) during a lipid tolerance test (LTT) in response to water or a gut-selective (14 g/mouse) or systemic (10 mg/kg) dose of sitagliptin in 5-hour fasted 16- to 19-week-old Dpp4 EC+/+ ( A and B , n = 1117/group), Dpp4 EC/ ( C and D , n = 1226/group), Dpp4 EC+/+ (BMT) ( E and F , n = 78/group), and Dpp4 EC/ (BMT) ( G and H , n = 78/group) mice fed a 45% high-fat (HF) diet for 69 weeks
Tivanisiran, a novel siRNA for the treatment of dry eye disease
While oral formulations are generally less potent than injectable versions, they may provide sufficient maintenance effects after initial weight loss on injectable medications
doi: 10.1016/j.bcp.2012.12.002 140 YeYChouGXWangHChuJHYuZL